visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Alnylam Pharmaceuticals

    Get Full Access

    Description

    • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; lumasiran for the treatment of advanced PH1 and recurrent renal stones; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; and vutrisiran for the treatment of ATTR amyloidosis. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
    • location

      Headquarters:675 West Kendall Street , Cambridge, Massachusetts, United States

      More
    • Alnylam Pharmaceuticals phone

      Phone Number: +1 617-551-8200

    • Alnylam Pharmaceuticals website

      Website: https://www.alnylam.com

    • Alnylam Pharmaceuticals employees

      Employees:1542

    • Alnylam Pharmaceuticals revenue

      Revenue:$250 - 500M

    • Alnylam Pharmaceuticals legal name

      Legal Name:Alnylam Pharmaceuticals

    • Alnylam Pharmaceuticals's Social Media

      Alnylam Pharmaceuticals linkedin Alnylam Pharmaceuticals facebook Alnylam Pharmaceuticals twitter
    • done Is this data correct?

    • |  NAICS Code: 541715  |

        NYSE: ALNY

      Show More
    Person level website identification

    CEO for Alnylam Pharmaceuticals

    John Maraganore

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Yvonne Greenstreet

    Chief Operations Officer

    Emmanuel Dulac

    Chief Creative Officer

    Jeff Poulton

    Chief Financial Officer

    Kevin Fitzgerald

    Chief Scientific Officer

    Indrani Franchini

    Executive Vice President And Chief Legal Officer

    Frequently Asked Questions regarding Alnylam Pharmaceuticals

    • Where are Alnylam Pharmaceuticals's Headquarters?

      Alnylam Pharmaceuticals's Headquarters are in 675 West Kendall Street ,Cambridge,Massachusetts,United States

    • What is Alnylam Pharmaceuticals's phone number?

      Alnylam Pharmaceuticals's phone number is +1 617-551-8200

    • What is Alnylam Pharmaceuticals's stock symbol?

      Alnylam Pharmaceuticals's stock symbol is ALNY

    • What is Alnylam Pharmaceuticals's official website?

      Alnylam Pharmaceuticals's official website is https://www.alnylam.com

    • What is Alnylam Pharmaceuticals's Revenue?

      Alnylam Pharmaceuticals's revenue is $250 - 500M

    • What is Alnylam Pharmaceuticals's NAICS code?

      Alnylam Pharmaceuticals's NAICS code is 541715

    • How many employees are working in Alnylam Pharmaceuticals

      Alnylam Pharmaceuticals has 1542 employees

    • What is Alnylam Pharmaceuticals's Industry?

      Alnylam Pharmaceuticals is in the industry of Biotechnology

    Company Directory